Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo-Controlled, Dose-Finding Study of the Effect of GTx-024 on Muscle Wasting (Cachexia) in Patients With Cancer

NCT00467844 is registered in ClinicalTrials.gov with GTx as lead sponsor.

NCT NCT00467844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00467844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo-Controlled, Dose-Finding Study of the Effect of GTx-024 on Muscle Wasting (Cachexia) in Patients With Cancer
Lead sponsor
GTx
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
September 30, 2008
Enrollment
159 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia